Kiran Sahasrabudhe

This inventor holds 7 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Signal Pharmaceuticals, Inc., Pharmacopeia Drug Discovery, Inc.. Active years: 2005-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kiran Sahasrabudhe. Retrieved from https://idiyas.com/inventor/kiran-sahasrabudhe

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 7

% Patents Active = 42.9

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 2

Average Co-Inventor Count = 12.3

ph-index = 7

Forward Citations = 152(Granted Patents)

Company Filing History:

7 out of 169

Signal Pharmaceuticals, Inc.

patents

1 out of 52

Pharmacopeia Drug Discovery, Inc.

patents

where one patent can have more than one assignee

Years Active: 2005-2012

Loading Chart...

7 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8101588 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2012-01-24),

2. 7723340 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2010-05-25),

3. 7521446 - Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith (2009-04-21),

4. 7220771 - Methods of using indazole derivatives as JNK inhibitors (2007-05-22),

5. 7211594 - Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith (2007-05-01),

6. 7208513 - Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith (2007-04-24),

7. 6897231 - Indazole derivatives as JNK inhibitors and compositions and methods related thereto (2005-05-24),

Title: Kiran Sahasrabudhe: Innovator in Aminopurine Compounds

Introduction: Kiran Sahasrabudhe is a prominent inventor based in San Diego, California, recognized for his contributions to the field of medicinal chemistry, particularly in the development of aminopurine compounds. With an impressive portfolio of seven patents, Sahasrabudhe has made significant strides in innovative treatments that could have a profound impact on healthcare.

Latest Patents: Among his latest innovations, Sahasrabudhe developed a patent titled "Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewith." This patent encompasses aminopurine compounds characterized by a specific structural composition. These compounds promise enhanced efficacy in various therapeutic applications, showcasing his commitment to advancing medicinal solutions.

Career Highlights: Kiran Sahasrabudhe has held pivotal roles in several influential companies. He has worked with Signal Pharmaceuticals, Inc., where he contributed to the drug discovery process, and Pharmacopeia Drug Discovery, Inc., where his research focused on novel therapeutic compounds. His work in these organizations has played a crucial role in the advancement of pharmaceutical research and development.

Collaborations: Throughout his career, Sahasrabudhe has collaborated with notable colleagues, including Ronald J. Albers and Yoshitaka Satoh. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas, further enhancing the quality and impact of their research endeavors.

Conclusion: Kiran Sahasrabudhe's dedication to innovation in the field of aminopurine compounds marks him as a valuable contributor to the scientific community. With his extensive patent portfolio and collaborative spirit, Sahasrabudhe continues to push boundaries in pharmaceutical research, paving the way for new treatments and therapies. His work exemplifies how inventors can influence the future of medicine through innovative discoveries.

Profile summary based on public USPTO records.